5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
- 1 August 2000
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 48 (3), 229-237
- https://doi.org/10.1016/s0006-3223(00)00850-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled TrialNeuropsychopharmacology, 1999
- Reversal of Haloperidol-Induced Extrapyramidal Side Effects in Cebus Monkeys by 8-Hydroxy-2-(di-n-propylamino)tetralin and Its EnantiomersNeuropsychopharmacology, 1998
- MDL 100,907: A Selective 5‐HT2A Receptor Antagonist for the Treatment of SchizophreniaCNS Drug Reviews, 1997
- Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptorsNeuropharmacology, 1996
- 3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic AgentsJournal of Medicinal Chemistry, 1996
- Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common groundSchizophrenia Research, 1995
- (R)‐8‐OH‐DPAT preferentially increases dopamine release in rat medial prefrontal cortexActa Physiologica Scandinavica, 1993
- Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsyJournal of Neural Transmission, 1991
- Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis StudyJournal of Neurochemistry, 1990
- 8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalisNeuropharmacology, 1988